bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Bright Minds Biosciences Inc. logo

    Bright Minds Biosciences Inc.

    DRUG | NASDAQ
    Chart Builder DCF Calculator
    $61.30
    +$1.84 (+3.09%)
    Sep 22, 2026, 12:58 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $581.94M
    Enterprise Value
    $517.8M
    Beta
    0.09
    Average Volume
    263.79K
    Shares Outstanding (Diluted)
    9.83M
    Shares Change YoY
    38.77%
    Institutional Ownership
    95.82%
    Exchange
    NASDAQ
    ISIN
    CA10919W4056

    Price Performance

    Price Change 1M
    -24.6%
    Price Change 3M
    -8.7%
    Price Change 6M
    -19.8%
    Price Change YTD
    -28.8%
    Price Change 1Y
    16.3%
    Price Change 3Y
    3337.0%
    Price Change 5Y
    69.6%
    1M CAGR (ann.)
    -25.1%
    1Y CAGR (ann.)
    18.6%
    5Y CAGR (ann.)
    16.8%
    All-Time CAGR
    15.4%

    Valuation

    PE Ratio
    -29.76
    Forward PE
    N/A
    PEG Ratio
    0.39
    Forward PEG
    -0.20
    PS Ratio
    N/A
    Forward PS
    27.00
    PB Ratio
    2.68
    P/FCF Ratio
    -32.16
    P/Adj. FCF Ratio
    -29.39
    P/OCF Ratio
    -32.34
    EV/Sales
    N/A
    EV/EBIT
    -15.22
    EV/EBITDA
    -15.26
    EV/FCF
    -20.71
    Earnings Yield
    -3.3%
    FCF Yield
    -3.1%
    Adj. FCF Yield
    -3.4%

    Financial Health

    Net Cash
    C$308.27M
    Total Debt
    C$65.7K
    Cash & Short-Term Investments
    C$308.33M
    Total Assets
    C$310.84M
    Current Ratio
    121.97
    Quick Ratio
    121.97
    Debt / Equity Ratio
    0.00
    Debt / EBITDA
    -0.00
    Debt / FCF
    -0.00
    OCF / Debt
    -380.52
    Interest Coverage
    -2,336.36
    Altman Z-Score
    195.04
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    0.0%
    Operating Profit Margin
    0.0%
    EBITDA Margin
    0.0%
    Net Profit Margin
    0.0%
    FCF Margin
    N/A
    Adj. FCF Margin
    N/A
    SBC / Revenue
    0.0%
    SBC Impact (per share)
    -9.4%

    Returns

    Return on Assets
    -8.0%
    Return on Equity
    -12.6%
    Return on Invested Capital
    -12.9%
    Return on Capital Employed
    -12.9%
    Return on Tangible Assets
    -8.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    N/A
    Revenue CAGR 5Y
    N/A
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    -52.6%
    EPS CAGR 5Y
    28.8%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -94.8%
    FCF CAGR 5Y
    -19.4%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    4
    EPS Growth Next 3Y
    -75.4%
    Revenue Growth Next 3Y
    N/A
    Earnings Date
    Dec 21, 2026
    EPS Estimate (next Q)
    -$0.76
    EPS Growth Est (next Q)
    161.0%
    Revenue Est (next Q)
    N/A
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $182.50
    Price Target Upside
    206.9%

    Cash Flow

    Operating Cash Flow
    C$-25M
    Free Cash Flow
    C$-25M
    Adj. Free Cash Flow
    C$-27.35M
    FCF Per Share
    -$2.54
    OCF Per Share
    -$2.54
    OCF/S Ratio
    0.0%

    Income Statement

    Revenue
    C$0
    Gross Profit
    C$-40.1K
    Operating Income
    C$-39.87M
    EBITDA
    C$-33.94M
    Net Income
    C$-24.75M
    EPS (Diluted)
    -$2.76
    Revenue / Employee
    N/A
    Profit / Employee
    $-951.8K
    Employees
    26

    © 2026 bestshares.com. All rights reserved.